Vivani Medical Inc. (VANI) - Total Liabilities
Based on the latest financial reports, Vivani Medical Inc. (VANI) has total liabilities worth $23.66 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore VANI net asset momentum to track the company's year-over-year net asset growth rate.
Vivani Medical Inc. - Total Liabilities Trend (2012–2025)
This chart illustrates how Vivani Medical Inc.'s total liabilities have evolved over time, based on quarterly financial data.
Vivani Medical Inc. Competitors by Total Liabilities
The table below lists competitors of Vivani Medical Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Havila Kystruten AS
OL:HKY
|
Norway | Nkr5.88 Billion |
|
Synchronoss Technologies Inc
NASDAQ:SNCR
|
USA | $222.87 Million |
|
NeoPharm CO. LTD
KQ:092730
|
Korea | ₩18.97 Billion |
|
Xtract One Technologies Inc.
TO:XTRA
|
Canada | CA$12.77 Million |
|
SA Catana Group
PA:CATG
|
France | €126.23 Million |
|
G J Steel Public Company Limited
BK:GJS
|
Thailand | ฿2.11 Billion |
|
Dongyang E&P Inc
KQ:079960
|
Korea | ₩91.21 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Vivani Medical Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Vivani Medical Inc. market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.60 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Vivani Medical Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Vivani Medical Inc. (2012–2025)
The table below shows the annual total liabilities of Vivani Medical Inc. from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $23.66 Million | -1.20% |
| 2024-12-31 | $23.95 Million | -4.33% |
| 2023-12-31 | $25.04 Million | +266.99% |
| 2022-12-31 | $6.82 Million | +128.31% |
| 2021-12-31 | $2.99 Million | -8.54% |
| 2020-12-31 | $3.27 Million | -64.96% |
| 2019-12-31 | $9.32 Million | +22.72% |
| 2018-12-31 | $7.60 Million | +14.86% |
| 2017-12-31 | $6.62 Million | +16.83% |
| 2016-12-31 | $5.66 Million | -29.07% |
| 2015-12-31 | $7.98 Million | -5.55% |
| 2014-12-31 | $8.45 Million | -61.40% |
| 2013-12-31 | $21.89 Million | +98.38% |
| 2012-12-31 | $11.04 Million | -- |
About Vivani Medical Inc.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the t… Read more